Singapore Health Promotion Board Renews Collaboration with CueZen to Scale AI-Driven Preventive Health

11 March 2026 | Wednesday | News

Partnership has delivered more than 400 million personalized health interventions nationwide, using AI-powered personalization to boost physical activity, healthier purchasing, and long-term engagement in preventive and chronic care programs.

Singapore Health Promotion Board Extends Collaboration with CueZen AI After Personalization Helps Millions Lead Healthier Lives

CueZen, an AI-native personalization platform for health, announced the renewal of its multi-year collaboration with the Singapore Health Promotion Board. The platform has delivered over four hundred million personalized health interventions nationwide, driving measurable improvements in physical activity, sleep, healthy purchases, and long-term engagement in preventive and chronic-care programs.

“There’s no shortage of data in healthcare—what’s missing is the ability to convert that data into meaningful, personal guidance, to drive sustained behavior change,” said Ankur Teredesai, CEO and Co-Founder of CueZen, part of the Microsoft for Startups program. “What we observe in Singapore Health Promotion Board is a thoughtful personalization that helps people at each stage of their health journey from building better daily habits, to managing chronic conditions with fewer setbacks and more support.”

The Singapore deployment represents one of the world’s first validated demonstrations of agentic AI-powered personalization at true population scale. Over an 18-month period, citizens clocked additional 44 billion steps, 243 million exercise minutes, and made 88 million healthy purchasing decisions. This is a quantifiable shift in behavior made possible through precise, moment-based digital interventions delivered to millions of individuals across the nation at the right time via the right channel, with the right tonality and frequency being mindful of their needs.

CueZen’s architecture, based on Microsoft Azure Virtual Machines and Azure Database for PostgreSQL, helps ensure compliance to data security, data residency and data privacy requirements, protected with government-grade security across diverse regulatory environments.

“We are entering a new era in health in which technology helps broaden access to insights that support more proactive and continuous engagement in care,” said Elena Bonfiglioli, Global Business Leader, GM Healthcare, Pharma and Life Sciences at Microsoft. “At Microsoft, we believe this transformation will be driven by AI that responsibly connects data, enhances clinical and operational workflows, and makes information easier to act on. Innovations like CueZen illustrate how personalized guidance and behavior support can be thoughtfully integrated into everyday health journeys. Together, these advancements help empower individuals, care teams, and organizations to drive better health experiences.”

CueZen was recently named a finalist for the 2025 Microsoft Partner of the Year Award, recognizing its groundbreaking innovation and the global impact of its Microsoft-based solutions.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close